Opioid Use Disorder
Research Study

Researchers at the University of Pennsylvania School of Medicine are conducting a research study to explore a new approach to starting methadone treatment for people with opioid use disorder who actively use fentanyl. The study will compare standard methadone dosing with a higher-dose approach, called loading-dose initiation, to better understand how it may help people begin methadone treatment with fewer withdrawal symptoms.

Fast Facts

Actively using fentanyl

Interested in starting methadone or buprenorphine treatment for opioid use

Compensation
provided

Conducted in
Philadelphia, PA

Additional Information

This study aims to identify a safe and appropriate methadone loading dose approach for people with opioid use disorder who use fentanyl. Researchers will compare this approach with standard methadone initiation to better understand its effects and how methadone levels change in the body.

You may be eligible for this study if you meet the following criteria.

Inclusion Criteria:

  • Actively using fentanyl
  • Interested in starting methadone treatment for opioid use disorder
  • Not taking buprenorphine or methadone
  • Able to participate in a 3 day inpatient stay for the study
  • Do not actively use benzodiazepines
  • Ages 18+

Participation includes an outpatient screening visit, a 3-day (2-night) inpatient stay, and follow-up phone calls.

Step 1: Outpatient Screening

You will meet with the research team in person to learn about the study and complete the informed consent process. Screening procedures may include:

  • Medical history and physical exam
  • Urine drug screening and pregnancy testing, if applicable
  • Blood work and an electrocardiogram (ECG)
  • Questionnaires about drug use and mental health assessments


Step 2: Inpatient Study (Days 1–3)

If you qualify and enroll, you will stay in the hospital for 3 days and 2 nights. During this time, you will be assigned to one of two groups:

  • One group will receive standard methadone dosing.
  • The other group will receive a higher-dose methadone approach.

The research team will monitor your health throughout the stay. Study procedures include vital sign checks, continuous oxygen monitoring, withdrawal and craving assessments, ECGs, urine drug screening, and blood sample collection (approximately 15 samples over three days). You will also complete questionnaires and other safety assessments.

Step 3: Transition to Ongoing Treatment (Day 3)

At the end of the inpatient stay, you will be directly connected with a Merakey clinic of your choice to continue methadone maintenance treatment. Available locations include:

  • Merakey Parkside: 5000 Parkside Avenue
  • Merakey Germantown: 5429 Germantown Avenue
  • Merakey North 4th Street: 1745 North 4th Street


Step 4: Follow-Up Phone Calls

The research team will contact you by phone on Days 3, 4, 8, and 31 to ask about your methadone treatment and substance use.

Participants may receive compensation for taking part in the study. Additional benefits include free blood work with results, a free consultation with a physician and nurse practitioner, and a free ECG. Lyft transportation is also offered to all participants who enroll in the inpatient portion of the study.

There is no cost for you to participate in our research study.